| Diagnosis | N | % | N | % | N | % | N | % | N | % |
|---|---|---|---|---|---|---|---|---|---|---|
| Endocervical adenocarcinoma | 14 | 0.2% | 4 | 0.2% | 6 | 0.4% | 0 | 0.0% | 24 | 0.3% |
| Squamous cell carcinoma | 40 | 0.6% | 35 | 2.0% | 7 | 0.5% | 2 | 3.8% | 84 | 0.9% |
| Other cervical carcinoma | 8 | 0.1% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 8 | 0.1% |
| AIS | 20 | 0.3% | 32 | 1.8% | 4 | 0.3% | 0 | 0.0% | 56 | 0.6% |
| HSIL/CIN3 | 705 | 11.3% | 814 | 46.8% | 18 | 1.3% | 1 | 1.9% | 1,538 | 16.4% |
| HSIL/CIN2 | 340 | 5.5% | 268 | 15.4% | 6 | 0.4% | 0 | 0.0% | 614 | 6.5% |
| LSIL | 1,379 | 22.1% | 267 | 15.4% | 54 | 4.0% | 4 | 7.5% | 1,704 | 18.1% |
| Benign changes | 2,668 | 42.8% | 214 | 12.3% | 688 | 50.4% | 41 | 77.4% | 3,611 | 38.4% |
| No pathological findings | 813 | 13.0% | 78 | 4.5% | 578 | 42.3% | 3 | 5.7% | 1,472 | 15.7% |
| Evaluation not possible | 245 | 3.9% | 27 | 1.6% | 3 | 0.2% | 2 | 3.8% | 277 | 2.9% |
| Data not available | 2 | 0.0% | 0 | 0.0% | 2 | 0.1% | 0 | 0.0% | 4 | 0.0% |
| Total | 6,234 | 100.0% | 1,739 | 100.0% | 1,366 | 100.0% | 53 | 100.0% | 9,392 | 100.0% |